Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Head-to-head comparison of MK-677 and Ipamorelin — mechanism, dosing, side effects, legal status, and pricing.
MK-677 (ibutamoren) is an orally active, non-peptide growth hormone secretagogue that mimics ghrelin's action. Despite not being a peptide, it is commonly tracked alongside GH-releasing peptides due to its similar mechanism and use case. It elevates GH and IGF-1 levels without affecting cortisol.
Ipamorelin is a selective growth hormone secretagogue that stimulates the pituitary gland to release growth hormone. It is considered one of the mildest GHRPs with fewer side effects than alternatives like GHRP-6.
MK-677
Ipamorelin
Category
Legal Status
Mechanism
Dose Range
Route
Frequency
Dosing Notes
Side Effects
Contraindications
Multiple clinical trials in elderly and GH-deficient populations demonstrate sustained increases in GH and IGF-1, improvements in body composition, increased bone density, and improved sleep quality. A 2-year trial showed sustained IGF-1 elevation without tachyphylaxis. Not FDA-approved despite extensive human data.
Key references
Clinical studies have demonstrated its ability to increase GH release in a dose-dependent manner. It has been studied in post-surgical recovery and bone health contexts. It is frequently combined with CJC-1295 for synergistic GH elevation.
MK-677 and Ipamorelin are both in the Performance category and may have overlapping mechanisms. Researchers should review both profiles carefully, understand the mechanisms of action, and monitor the relevant biomarkers when combining compounds in the same class. As always, consult a licensed healthcare provider before making any decisions about combining research compounds.
This platform provides informational tools only, not medical advice. This comparison is for educational purposes only. Consult a licensed provider.
Disclosed Labs